Shandong, China

Changwei Shao

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Fishery Sciences. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Changwei Shao. Retrieved from https://idiyas.com/inventor/changwei-shao-dltsimc7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Changwei Shao: Innovator in Medicinal Microorganisms

Introduction

Changwei Shao is a prominent inventor based in Shandong, China. He has made significant contributions to the field of medicinal microorganisms, particularly in the production of tetrodotoxin. His innovative work has implications for both medicine and biotechnology.

Latest Patents

Changwei Shao holds a patent for producing tetrodotoxin and its application. This patent discloses a method for producing tetrodotoxin, which is a potent neurotoxin. The strain S3-4, which he developed, is deposited in the China General Microbiological Culture Collection Center (CGMCC) with the deposit number CGMCC No. 24602. This strain can secrete a substance similar to tetrodotoxin found in Tetraodontidae.

Career Highlights

Changwei Shao is affiliated with the Chinese Academy of Fishery Sciences. His work at this institution has allowed him to explore the development and utilization of medicinal microorganisms. His research has garnered attention for its potential applications in various fields.

Collaborations

Some of his notable coworkers include Qian Wang and Yuyan Liu. Their collaborative efforts contribute to the advancement of research in medicinal microorganisms.

Conclusion

Changwei Shao's innovative work in the production of tetrodotoxin showcases his expertise in the field of medicinal microorganisms. His contributions are paving the way for future advancements in biotechnology and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…